查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829237

2025年全球分子診斷設備與儀器市場報告

Molecular Diagnostics Devices And Equipment Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，分子診斷設備和器械市場規模快速擴張，從2024年的244億美元成長到2025年的272.3億美元，複合年成長率為11.6%。這段時期的成長可歸因於資金籌措的增加、醫療支出的增加、新興市場的經濟成長、技術的快速進步、新型性行為感染的出現以及老年人口的快速成長。

預計未來幾年分子診斷儀器和設備市場規模將快速成長，到 2029 年將達到 425.9 億美元，複合年成長率為 11.8%。預測期內的成長可歸因於各種細菌和病毒性傳染病的激增、人口老化、醫療保健機會的增加、慢性病盛行率的上升以及 COVID-19，這些因素將增加對分子診斷儀器和設備的需求。預測期內的主要趨勢包括分子診斷領域的自動化、人工智慧的使用、罕見疾病研究中對分子診斷儀器的需求不斷成長、巨量資料的日益普及、用於新生兒篩檢的下一代定序以及照護現場分子診斷 (POC mdx)。

分子診斷設備透過檢測特定的 DNA 或 RNA 序列來診斷和篩檢感染疾病，這有助於指導更精確的治療性介入，特別是在疾病的早期階段。

分子診斷產品包括儀器、試劑和耗材。本文中的試劑是指用於引發化學反應的物質，通常用於指示某種物質的存在。分子診斷涉及多種技術，包括DNA（去氧核糖核酸）序列測定、聚合酵素鏈鎖反應、恒溫核酸增幅技術、轉錄媒介增幅（TMA）、原位雜合反應、微陣列、質譜、Southern印跡、Northern印跡和電泳。這些技術應用於癌症診斷、藥物基因體學、基因檢測、感染疾病檢測、產前篩檢、神經系統疾病分析和心血管疾病評估。分子診斷儀器被各種最終用戶使用，包括診斷實驗室、醫院、老人安養院、血庫和照護現場機構。

2025年春季，美國關稅飆升及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）全新研究報告系列的一部分，該系列提供分子診斷設備（或器械）市場統計數據，例如全球市場規模、各地區市場佔有率、競爭對手的市場佔有率、分子診斷設備（或器械）市場的細分、市場趨勢和商機，以及在分子診斷設備（或器械）行業取得成功所需的其他數據。本分子診斷設備（或器材）市場研究報告透過對產業現狀和未來趨勢的詳細分析，為您提供全面的產業展望。

未來五年11.8%的成長預測，較我們先前對該市場的預測略有下降0.3%。下降的主要原因是美國與其他國家之間的關稅影響，這將直接影響美國，包括新加坡微流體晶片供應鏈中斷、就地檢驗設備生產延遲以及感染疾病檢測系統成本上升。

感染疾病的日益流行預計將在未來推動分子診斷設備市場的成長。感染疾病是由細菌、病毒、真菌和寄生蟲等病原微生物引起的疾病，並在人與人之間或從動物傳播給人。導致感染疾病增加的因素包括抗生素抗藥性、全球化和旅行、都市化、社會經濟差距以及人口老化。分子診斷設備和儀器是檢測和管理這些疾病的重要工具。例如，2023 年 3 月，英國政府國家統計局報告稱，截至 2023 年 3 月 17 日的一周內，英國記錄了 619 例與 COVID-19 相關的死亡病例，高於前一周的 605 例。在那一周，COVID-19 死亡人數佔英國所有死亡人數的 4.5%，略低於前一周的 4.6%。因此，感染疾病的日益普及正在推動分子診斷設備市場的成長。

慢性病盛行率的不斷上升預計將推動分子診斷設備和儀器市場的未來成長。慢性病，又稱非傳染性疾病 (NCD)，是指進展緩慢且持續較長的健康狀況。分子診斷設備和儀器在慢性病的診斷、監測和管理中發揮關鍵作用，使醫療保健專業人員能夠分析與這些疾病相關的遺傳、分子和生化標記。例如，2022 年 3 月，美國國家生物技術資訊中心報告稱，印度 21% 的老年人患有至少一種慢性病，其中高血壓和糖尿病約佔所有慢性病的 68%。這凸顯了分子診斷在慢性病管理中將扮演的重要角色。

分子診斷產業的主要參與企業正致力於開發用於分子診斷流程的儀器和設備的自動化解決方案。自動化提高了診斷過程的生產力和一致性，與手動方法相比，能夠提供更可靠、更有效率的檢測結果。基於奈米技術的解決方案，例如用於檢測唾液中口腔癌生物標記的口腔液奈米感測器檢測 (OFNASET)，正在廣泛應用。為了順應自動化和精準化趨勢，羅氏推出了 Cobas 連接模組 (CCM)，該模組透過實現不同系統和儀器之間的自動樣品轉移，從而提高可擴展性和樣品流效率，最終實現完全自動化的工作流程。

分子診斷設備和儀器市場的主要企業正在創新和開發產品，例如用於分子診斷的高性能「樣本到結果」儀器。例如，ELITechGroup 於 2023 年 4 月推出了基於其成熟的提取和分析技術的高性能「樣本到結果」儀器。該儀器可連續加載樣品和試劑，並具有真正的隨機存取功能，使用戶可以靈活地並行運行不同的 PCR 試劑、通訊協定和樣品基質。

2022年2月，印度製造公司Tulip Diagnostics收購了Biosense Technologies，收購金額未揭露。 Tulip Diagnostics旨在透過此次收購提升其就地檢驗能力並擴展產品系列。 Biosense Technologies也位於印度，專注於開發創新的分子診斷設備，以增強疾病檢測能力並提供個人化的醫療保健解決方案。

分子診斷器材與設備市場的主要企業包括 F. Hoffmann-La Roche Ltd、QIAGEN NV、Abbott Laboratories、Danaher Corporation、Biomerieux、Becton Dickinson & Co、Siemens Healthineers AG、Grifols SA、Sysmex Corporation、Abbott India Limited、Qiagen India Limited Scientific、浙江迪安診斷技術股份有限公司、ADICON Clinical Laboratories、廣州金域醫學檢驗中心股份有限公司、Kindstar Global、深華大基因、OriGene Technologies、拜耳股份公司、強生公司、Nippon Becton Dickinson Company、QuantuMDx、Your Health、Genefirst、Interlabservis、Geneon Dickinson Company、Mlloxx、Yourest、Genefirst、Interlabservis、GenelinConet. Inc.、諾華股份公司、Cepheid Inc.、Admera Health、安捷倫科技公司AutoGenomics、Bio-Red Laboratories Inc.、Ortho Clinical Diagnostics Inc.、Sysmex Middle East FZ-LLC 和 QIAGEN SA (Pty) Ltd.

2024年，亞太地區是最大的分子診斷設備市場。西歐是第二大分子診斷設備市場。分子診斷設備和儀器市場報告涵蓋以下地區：亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

分子診斷器材與設備市場報告涵蓋的國家：澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、英國、美國、加拿大、西班牙

分子診斷設備和儀器市場包括熱迴圈儀、單粒子質譜儀、飛行時間質譜儀 (TOF) 以及其他用於檢測病原體和感染疾病的儀器的銷售。此市場的價值以出廠價計算，即商品製造商或生產者向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。此市場細分為儀器、試劑和耗材。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球分子診斷設備與儀器：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球分子診斷器材與設備市場：成長率分析
  • 全球分子診斷設備與儀器市場表現：規模與成長，2019-2024
  • 全球分子診斷器材與設備市場預測：規模和成長，2024-2029 年，2034 年
  • 全球分子診斷儀器與設備：總目標市場（TAM）

第6章 市場細分

  • 全球分子診斷器材與設備市場（按產品、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 裝置
  • 試劑和耗材
  • 軟體
  • 全球分子診斷器材與設備市場（按技術、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • DNA（去氧核糖核酸）序列測定
  • 聚合酵素鏈鎖反應
  • 恒溫核酸增幅技術
  • 轉錄介導擴增（TMA）
  • 原位雜合反應
  • 微陣列
  • 質譜法
  • 其他
  • 全球分子診斷器材與設備市場的應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 癌症
  • 藥物基因組學
  • 基因檢測
  • 感染疾病
  • 產前
  • 其他
  • 全球分子診斷器材與設備市場（按最終用戶、效能和預測），2019-2024 年、2024-2029 年、2034 年
  • 診斷實驗室
  • 醫院
  • 其他
  • 全球分子診斷設備和儀器市場：設備細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 聚合酵素鏈鎖反應（PCR）設備
  • 核酸分析儀
  • DNA定序儀
  • 微陣列
  • 全球分子診斷設備和儀器市場：試劑和耗材細分、按類型、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • PCR試劑
  • DNA探針和引子
  • 樣品製備套件
  • 控制和校準材料
  • 全球分子診斷器材與設備市場：軟體細分，按類型、效能和預測，2019-2024 年、2024-2029 年、2034 年
  • 數據分析軟體
  • 實驗室資訊管理系統（LIMS）
  • 生物資訊軟體
  • 測量儀器整合軟體

第7章 區域和國家分析

  • 全球分子診斷器材與設備市場：區域表現與預測，2019-2024年，2024-2029年，2034年
  • 全球分子診斷器材與設備市場：國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 分子診斷器材與設備市場：競爭格局
  • 分子診斷器材與設備市場：公司簡介
    • F. Hoffmann-La Roche Ltd
    • QIAGEN NV
    • Abbott Laboratories
    • Danaher Corporation
    • Biomerieux

第31章：其他領先和創新企業

  • Becton Dickinson & Co
  • Siemens Healthineers AG
  • Grifols SA
  • Sysmex Corporation
  • Abbott India Limited
  • Qiagen India Pvt Ltd
  • Biocartis
  • Bio-Techne India Private Limited
  • Cleaver Scientific
  • Zhejiang Di'an Diagnostics Technology Co. Ltd
  • ADICON Clinical Laboratories
  • Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • Kindstar Global
  • BGI-Shenzhen
  • OriGene Technologies

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年分子診斷器材與設備市場：提供新機會的國家
  • 2029年分子診斷器材與設備市場：細分市場將帶來新機會
  • 2029年分子診斷器材與設備市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r25800u

Molecular diagnostics devices are utilized for the diagnosis of infectious diseases and screening by detecting specific sequences in DNA or RNA. These devices aid in providing more accurate therapeutic interventions, especially in the early stages of a disease.

The main products of molecular diagnostics devices include instruments, reagents, and consumables. Reagents, in this context, refer to substances used to cause a chemical reaction, often employed to indicate the presence of another substance. Various technologies are involved in molecular diagnostics, such as DNA (deoxyribonucleic acid) sequencing, polymerase chain reaction, isothermal nucleic acid amplification technology, transcription-mediated amplification (TMA), in situ hybridization, microarrays, mass spectrometry, and others such as southern blotting, northern blotting, and electrophoresis. These technologies find applications in cancer diagnosis, pharmacogenomics, genetic testing, infectious disease detection, prenatal screening, neurological disease analysis, and cardiovascular disease assessment. Molecular diagnostics devices are used by various end-users, including diagnostic laboratories, hospitals, and others such as nursing homes, blood banks, and point-of-care facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The molecular diagnostics devices (or) equipment market research report is one of a series of new reports from The Business Research Company that provides molecular diagnostics devices (or) equipment market statistics, including molecular diagnostics devices (or) equipment industry global market size, regional shares, competitors with a molecular diagnostics devices (or) equipment market share, detailed molecular diagnostics devices (or) equipment market segments, market trends and opportunities, and any further data you may need to thrive in the molecular diagnostics devices (or) equipment industry. This molecular diagnostics devices (or) equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The molecular diagnostics devices and equipment market size has grown rapidly in recent years. It will grow from $24.4 billion in 2024 to $27.23 billion in 2025 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to rise in funding, increase in healthcare expenditure, economic growth in emerging markets, rapid technological advances, emergence of novel pathogenic infestations, and rapid growth in geriatric population.

The molecular diagnostics devices and equipment market size is expected to see rapid growth in the next few years. It will grow to $42.59 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to rapid rise in various bacterial and viral epidemics, aging population, increase in healthcare access, rising prevalence of chronic diseases and increasing demand for molecular diagnostic devices and equipment due to COVID-19. Major trends in the forecast period include automation in the field of molecular diagnostics, use of artificial intelligence, increased demand for molecular diagnostic devices in studying rare diseases, growing adoption of big data, next generation sequencing for newborn screening, and point-of-care molecular diagnostics (POC mdx).

The forecast of 11.8% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for microfluidic chips from Singapore, delaying production of point-of-care testing devices and increasing costs for infectious disease detection systems.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing incidence of infectious diseases is expected to drive the growth of the molecular diagnostic devices and equipment market in the future. Infectious diseases are illnesses caused by pathogenic microorganisms, such as bacteria, viruses, fungi, or parasites, which can be transmitted between individuals or from animals to humans. Factors contributing to the rise in infectious diseases include antimicrobial resistance, globalization and travel, urbanization, socioeconomic disparities, and an aging population. Molecular diagnostic devices and equipment are critical tools for the detection and management of these diseases. For example, in March 2023, the Office for National Statistics, a UK government department, reported that during the week ending March 17, 2023, the UK recorded 619 deaths related to COVID-19, an increase from 605 the previous week. During that week, COVID-19 deaths accounted for 4.5% of all deaths in the UK, a slight decrease from 4.6% the week before. Thus, the rising incidence of infectious diseases is propelling the growth of the molecular diagnostic devices and equipment market.

The increasing incidence of chronic diseases is anticipated to drive the future growth of the molecular diagnostics devices and equipment market. Chronic diseases, or non-communicable diseases (NCDs), are persistent health conditions that progress slowly and endure for an extended period. Molecular diagnostics devices and equipment play a crucial role in the diagnosis, monitoring, and management of chronic diseases by enabling healthcare professionals to analyze genetic, molecular, and biochemical markers associated with these conditions. For instance, in March 2022, The National Center for Biotechnology Information reported that 21% of the elderly population in India has at least one chronic disease, with hypertension and diabetes accounting for about 68% of all chronic diseases. This highlights the significant role of molecular diagnostics in managing chronic conditions.

Key players in the molecular diagnostic industry are focusing on developing automated solutions for devices and equipment used in molecular diagnostic processes. Automation enhances productivity and consistency in the diagnostic process, providing reliable and efficient test results compared to manual testing. Nanotechnology-based solutions, such as the Oral Fluid Nano Sensor Test (OFNASET) for detecting oral cancer biomarkers in saliva, are being utilized. To align with the trend of automation and accuracy, Roche introduced cobas connection modules (CCM) to improve scalability and sample-flow efficiency by enabling the automatic movement of samples between different systems and instruments, creating a fully automated workflow.

Major companies in the molecular diagnostics devices and equipment market are innovating by developing products such as high-throughput sample-to-result instruments for molecular diagnostics. ELITechGroup, for instance, launched a high-throughput sample-to-result instrument in April 2023, based on its proven extraction and assay technology. The instrument allows continuous loading of samples and reagents with real random-access capability, providing users with the flexibility to run different PCR reagents, protocols, and sample matrices in parallel.

In February 2022, Tulip Diagnostics, an India-based manufacturing company, acquired Biosense Technologies for an undisclosed amount. With this acquisition, Tulip Diagnostics aims to improve its point-of-care testing capabilities and expand its product portfolio. Biosense Technologies, also based in India, specializes in developing innovative molecular diagnostic devices that enhance disease detection and offer personalized healthcare solutions.

Major companies operating in the molecular diagnostics devices and equipment market include F. Hoffmann-La Roche Ltd, QIAGEN N.V., Abbott Laboratories, Danaher Corporation, Biomerieux, Becton Dickinson & Co, Siemens Healthineers AG, Grifols S.A., Sysmex Corporation, Abbott India Limited, Qiagen India Pvt Ltd, Biocartis, Bio-Techne India Private Limited, Cleaver Scientific, Zhejiang Di'an Diagnostics Technology Co. Ltd, ADICON Clinical Laboratories, Guangzhou Kingmed Diagnostics Center Co. Ltd., Kindstar Global, BGI-Shenzhen, OriGene Technologies, Bayer AG, Johnson & Johnson, Nippon Becton Dickinson Company, QuantuMDx, Yourgene Health, Genefirst, Interlabservis, GeneMe, TestLine, Clinical Diagnostics s.r.o, Hologic Inc., Illumina Inc., Novartis AG, Cepheid Inc., Admera Health, Agilent technologies Inc., AutoGenomics, Bio-Red Laboratories Inc, Ortho Clinical Diagnostics Inc, Sysmex Middle East FZ-LLC, QIAGEN SA (Pty) Ltd.

Asia-Pacific was the largest region in the global molecular diagnostics devices (or) equipment market in 2024. Western Europe was the second largest market in molecular diagnostics devices (or) equipment market. The regions covered in the molecular diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the molecular diagnostics devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The molecular diagnostics devices and equipment market consist of sales of thermocycler, single particle mass spectrometers, time-of-flight mass spectrometer (TOF) and others that are used to detect pathogen and infectious diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. This market is segmented into instruments, reagents, and consumables.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Molecular Diagnostics Devices And Equipment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on molecular diagnostics devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for molecular diagnostics devices and equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The molecular diagnostics devices and equipment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Instruments, Reagents And Consumables, Software
  • 2) By Technology: DNA(Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies
  • 3) By Application: Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications
  • 4) By End User: Diagnostic laboratories, Hospitals, Other End Users
  • Subsegments:
  • 1) By Instruments: Polymerase Chain Reaction (PCR) Machines; Nucleic Acid Analyzers; DNA Sequencers; Microarrays
  • 2) By Reagents And Consumables: PCR Reagents; DNA Probes And Primers; Sample Preparation Kits; Control And Calibration Materials
  • 3) By Software: Data Analysis Software; Laboratory Information Management Systems (LIMS); Bioinformatics Software; Integration Software For Instrumentation
  • Companies Mentioned: F. Hoffmann-La Roche Ltd; QIAGEN N.V.; Abbott Laboratories; Danaher Corporation; Biomerieux; Becton Dickinson & Co; Siemens Healthineers AG; Grifols S.A.; Sysmex Corporation; Abbott India Limited; Qiagen India Pvt Ltd; Biocartis; Bio-Techne India Private Limited; Cleaver Scientific; Zhejiang Di'an Diagnostics Technology Co. Ltd; ADICON Clinical Laboratories; Guangzhou Kingmed Diagnostics Center Co. Ltd.; Kindstar Global; BGI-Shenzhen; OriGene Technologies; Bayer AG; Johnson & Johnson; Nippon Becton Dickinson Company; QuantuMDx; Yourgene Health; Genefirst; Interlabservis; GeneMe; TestLine; Clinical Diagnostics s.r.o; Hologic Inc.; Illumina Inc.; Novartis AG; Cepheid Inc.; Admera Health; Agilent technologies Inc.; AutoGenomics; Bio-Red Laboratories Inc; Ortho Clinical Diagnostics Inc; Sysmex Middle East FZ-LLC; QIAGEN SA (Pty) Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Molecular Diagnostics Devices And Equipment Market Characteristics

3. Molecular Diagnostics Devices And Equipment Market Trends And Strategies

4. Molecular Diagnostics Devices And Equipment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Molecular Diagnostics Devices And Equipment Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Molecular Diagnostics Devices And Equipment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Molecular Diagnostics Devices And Equipment Market Growth Rate Analysis
  • 5.4. Global Molecular Diagnostics Devices And Equipment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Molecular Diagnostics Devices And Equipment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Molecular Diagnostics Devices And Equipment Total Addressable Market (TAM)

6. Molecular Diagnostics Devices And Equipment Market Segmentation

  • 6.1. Global Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Reagents And Consumables
  • Software
  • 6.2. Global Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • DNA(Deoxyribonucleic acid) sequencing
  • Polymerase chain reaction
  • Isothermal Nucleic Acid Amplification Technology
  • Transcription Mediated Amplification (TMA)
  • In situ hybridization
  • Microarrays
  • Mass spectrometry
  • Other Technologies
  • 6.3. Global Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer
  • Pharmacogenomics
  • Genetic testing
  • Infectious disease
  • Prenatal
  • Other Applications
  • 6.4. Global Molecular Diagnostics Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic laboratories
  • Hospitals
  • Other End Users
  • 6.5. Global Molecular Diagnostics Devices And Equipment Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR) Machines
  • Nucleic Acid Analyzers
  • DNA Sequencers
  • Microarrays
  • 6.6. Global Molecular Diagnostics Devices And Equipment Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • PCR Reagents
  • DNA Probes And Primers
  • Sample Preparation Kits
  • Control And Calibration Materials
  • 6.7. Global Molecular Diagnostics Devices And Equipment Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data Analysis Software
  • Laboratory Information Management Systems (LIMS)
  • Bioinformatics Software
  • Integration Software For Instrumentation

7. Molecular Diagnostics Devices And Equipment Market Regional And Country Analysis

  • 7.1. Global Molecular Diagnostics Devices And Equipment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Molecular Diagnostics Devices And Equipment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Molecular Diagnostics Devices And Equipment Market

  • 8.1. Asia-Pacific Molecular Diagnostics Devices And Equipment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Molecular Diagnostics Devices And Equipment Market

  • 9.1. China Molecular Diagnostics Devices And Equipment Market Overview
  • 9.2. China Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Molecular Diagnostics Devices And Equipment Market

  • 10.1. India Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Molecular Diagnostics Devices And Equipment Market

  • 11.1. Japan Molecular Diagnostics Devices And Equipment Market Overview
  • 11.2. Japan Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Molecular Diagnostics Devices And Equipment Market

  • 12.1. Australia Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Molecular Diagnostics Devices And Equipment Market

  • 13.1. Indonesia Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Molecular Diagnostics Devices And Equipment Market

  • 14.1. South Korea Molecular Diagnostics Devices And Equipment Market Overview
  • 14.2. South Korea Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Molecular Diagnostics Devices And Equipment Market

  • 15.1. Western Europe Molecular Diagnostics Devices And Equipment Market Overview
  • 15.2. Western Europe Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Molecular Diagnostics Devices And Equipment Market

  • 16.1. UK Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Molecular Diagnostics Devices And Equipment Market

  • 17.1. Germany Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Molecular Diagnostics Devices And Equipment Market

  • 18.1. France Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Molecular Diagnostics Devices And Equipment Market

  • 19.1. Italy Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Molecular Diagnostics Devices And Equipment Market

  • 20.1. Spain Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Molecular Diagnostics Devices And Equipment Market

  • 21.1. Eastern Europe Molecular Diagnostics Devices And Equipment Market Overview
  • 21.2. Eastern Europe Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Molecular Diagnostics Devices And Equipment Market

  • 22.1. Russia Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Molecular Diagnostics Devices And Equipment Market

  • 23.1. North America Molecular Diagnostics Devices And Equipment Market Overview
  • 23.2. North America Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Molecular Diagnostics Devices And Equipment Market

  • 24.1. USA Molecular Diagnostics Devices And Equipment Market Overview
  • 24.2. USA Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Molecular Diagnostics Devices And Equipment Market

  • 25.1. Canada Molecular Diagnostics Devices And Equipment Market Overview
  • 25.2. Canada Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Molecular Diagnostics Devices And Equipment Market

  • 26.1. South America Molecular Diagnostics Devices And Equipment Market Overview
  • 26.2. South America Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Molecular Diagnostics Devices And Equipment Market

  • 27.1. Brazil Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Molecular Diagnostics Devices And Equipment Market

  • 28.1. Middle East Molecular Diagnostics Devices And Equipment Market Overview
  • 28.2. Middle East Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Molecular Diagnostics Devices And Equipment Market

  • 29.1. Africa Molecular Diagnostics Devices And Equipment Market Overview
  • 29.2. Africa Molecular Diagnostics Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Molecular Diagnostics Devices And Equipment Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Molecular Diagnostics Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Molecular Diagnostics Devices And Equipment Market Competitive Landscape And Company Profiles

  • 30.1. Molecular Diagnostics Devices And Equipment Market Competitive Landscape
  • 30.2. Molecular Diagnostics Devices And Equipment Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. QIAGEN N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Biomerieux Overview, Products and Services, Strategy and Financial Analysis

31. Molecular Diagnostics Devices And Equipment Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson & Co
  • 31.2. Siemens Healthineers AG
  • 31.3. Grifols S.A.
  • 31.4. Sysmex Corporation
  • 31.5. Abbott India Limited
  • 31.6. Qiagen India Pvt Ltd
  • 31.7. Biocartis
  • 31.8. Bio-Techne India Private Limited
  • 31.9. Cleaver Scientific
  • 31.10. Zhejiang Di'an Diagnostics Technology Co. Ltd
  • 31.11. ADICON Clinical Laboratories
  • 31.12. Guangzhou Kingmed Diagnostics Center Co. Ltd.
  • 31.13. Kindstar Global
  • 31.14. BGI-Shenzhen
  • 31.15. OriGene Technologies

32. Global Molecular Diagnostics Devices And Equipment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Molecular Diagnostics Devices And Equipment Market

34. Recent Developments In The Molecular Diagnostics Devices And Equipment Market

35. Molecular Diagnostics Devices And Equipment Market High Potential Countries, Segments and Strategies

  • 35.1 Molecular Diagnostics Devices And Equipment Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Molecular Diagnostics Devices And Equipment Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Molecular Diagnostics Devices And Equipment Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer